STRATA Skin Sciences, Inc. (SSKN)
USD 2.59
(-1.19%)
USD 2.59
(-1.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 18.46 Million USD | -15.19% |
| 2022 | 21.76 Million USD | 9.66% |
| 2021 | 19.85 Million USD | 40.44% |
| 2020 | 14.13 Million USD | -30.27% |
| 2019 | 20.27 Million USD | 18.4% |
| 2018 | 17.12 Million USD | -4.63% |
| 2017 | 17.95 Million USD | -6.12% |
| 2016 | 19.12 Million USD | 300.36% |
| 2015 | 4.77 Million USD | 218.81% |
| 2014 | -4.02 Million USD | -5.65% |
| 2013 | -3.8 Million USD | -115.72% |
| 2012 | -1.76 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 100.0% |
| 2000 | -38 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.09 Million USD | -35.58% |
| 2024 Q2 | 4.94 Million USD | 59.62% |
| 2023 FY | 18.46 Million USD | -15.19% |
| 2023 Q1 | 4.38 Million USD | -35.92% |
| 2023 Q3 | 4.95 Million USD | 14.73% |
| 2023 Q4 | 4.8 Million USD | -3.09% |
| 2023 Q2 | 4.31 Million USD | -1.6% |
| 2022 Q1 | 4.12 Million USD | -38.96% |
| 2022 FY | 21.76 Million USD | 9.66% |
| 2022 Q4 | 6.84 Million USD | 18.09% |
| 2022 Q3 | 5.79 Million USD | 16.14% |
| 2022 Q2 | 4.99 Million USD | 20.95% |
| 2021 Q3 | 5.37 Million USD | 12.92% |
| 2021 Q2 | 4.76 Million USD | 28.23% |
| 2021 Q1 | 3.71 Million USD | -18.23% |
| 2021 FY | 19.85 Million USD | 40.44% |
| 2021 Q4 | 6.76 Million USD | 25.8% |
| 2020 Q2 | 1.96 Million USD | -55.35% |
| 2020 Q1 | 4.39 Million USD | -28.19% |
| 2020 Q3 | 3.23 Million USD | 64.46% |
| 2020 FY | 14.13 Million USD | -30.27% |
| 2020 Q4 | 4.54 Million USD | 40.59% |
| 2019 Q2 | 4.91 Million USD | 6.53% |
| 2019 Q4 | 6.12 Million USD | 32.45% |
| 2019 Q1 | 4.6 Million USD | -9.09% |
| 2019 Q3 | 4.62 Million USD | -5.8% |
| 2019 FY | 20.27 Million USD | 18.4% |
| 2018 Q4 | 5.07 Million USD | 4.69% |
| 2018 Q2 | 4.03 Million USD | 27.22% |
| 2018 Q1 | 3.17 Million USD | -13.81% |
| 2018 FY | 17.12 Million USD | -4.63% |
| 2018 Q3 | 4.84 Million USD | 20.05% |
| 2017 Q3 | 4.2 Million USD | -23.96% |
| 2017 Q2 | 5.52 Million USD | 21.81% |
| 2017 Q1 | 4.53 Million USD | -19.32% |
| 2017 FY | 17.95 Million USD | -6.12% |
| 2017 Q4 | 3.67 Million USD | -12.49% |
| 2016 Q1 | 4.19 Million USD | -29.88% |
| 2016 Q4 | 5.62 Million USD | 19.78% |
| 2016 Q3 | 4.69 Million USD | 2.11% |
| 2016 FY | 19.12 Million USD | 300.36% |
| 2016 Q2 | 4.6 Million USD | 9.58% |
| 2015 Q4 | 5.98 Million USD | 13.37% |
| 2015 Q1 | -629.68 Thousand USD | 21.84% |
| 2015 FY | 4.77 Million USD | 218.81% |
| 2015 Q3 | 5.28 Million USD | 190.07% |
| 2015 Q2 | -5.86 Million USD | -831.11% |
| 2014 Q4 | -805.6 Thousand USD | 39.95% |
| 2014 FY | -4.02 Million USD | -5.65% |
| 2014 Q3 | -1.34 Million USD | -27.54% |
| 2014 Q2 | -1.05 Million USD | -28.14% |
| 2014 Q1 | -820.88 Thousand USD | -6.1% |
| 2013 Q1 | -936.16 Thousand USD | -10.31% |
| 2013 FY | -3.8 Million USD | -115.72% |
| 2013 Q4 | -773.7 Thousand USD | 58.6% |
| 2013 Q3 | -1.86 Million USD | -51.07% |
| 2013 Q2 | -1.23 Million USD | -32.14% |
| 2012 Q1 | -119.16 Thousand USD | 0.0% |
| 2012 FY | -1.76 Million USD | 0.0% |
| 2012 Q4 | -848.64 Thousand USD | -69.81% |
| 2012 Q3 | -499.77 Thousand USD | -68.68% |
| 2012 Q2 | -296.29 Thousand USD | -148.65% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | -4.96 Billion USD | 0.0% |
| 2011 Q4 | - USD | 100.0% |
| 2011 Q3 | -6.12 Billion USD | -26.91% |
| 2011 Q2 | -4.82 Billion USD | 2.83% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q1 | 186.55 Million USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | -4.6 Billion USD | -2566.21% |
| 2010 Q3 | -4.96 Billion USD | -8.02% |
| 2009 Q4 | - USD | 100.0% |
| 2009 Q2 | -3.87 Billion USD | 4.65% |
| 2009 Q1 | -4.06 Billion USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | -5.06 Billion USD | -30.77% |
| 2008 Q4 | - USD | 100.0% |
| 2008 Q3 | -4.36 Billion USD | 14.33% |
| 2008 Q2 | -5.09 Billion USD | -5955.02% |
| 2008 Q1 | 87.08 Million USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 100.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | -3.02 Billion USD | 0.0% |
| 2007 Q1 | 87.08 Million USD | 15540.07% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | -564 Thousand USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 100.0% |
| 2000 FY | -38 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -623.961% |
| BrainsWay Ltd. | 23.09 Million USD | 20.051% |
| Cerus Corporation | 86.4 Million USD | 78.633% |
| Envoy Medical, Inc. | -473 Thousand USD | 4002.96% |
| electroCore, Inc. | 13.22 Million USD | -39.581% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -30163.933% |
| IceCure Medical Ltd | 1.3 Million USD | -1320.077% |
| Inogen, Inc. | 126.69 Million USD | 85.429% |
| OrthoPediatrics Corp. | 111.25 Million USD | 83.406% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 405.14% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 39099.913% |
| MaxCyte, Inc. | 36.54 Million USD | 49.486% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -3943.88% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -21603.502% |
| Orthofix Medical Inc. | 486.27 Million USD | 96.204% |
| PAVmed Inc | -3.96 Million USD | 565.247% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 436.572% |
| RxSight, Inc. | 53.76 Million USD | 65.664% |
| Sight Sciences, Inc. | 69.17 Million USD | 73.313% |
| SI-BONE, Inc. | 109.42 Million USD | 83.128% |
| TELA Bio, Inc. | 40.11 Million USD | 53.976% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 87.85% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -123.202% |
| Acutus Medical, Inc. | -3.13 Million USD | 688.492% |
| Talis Biomedical Corporation | 371 Thousand USD | -4876.011% |
| Spectral AI, Inc. | 7.88 Million USD | -134.277% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 380.052% |
| CVRx, Inc. | 33.03 Million USD | 44.124% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -2396.329% |
| Bioventus Inc. | 328.19 Million USD | 94.375% |
| Venus Concept Inc. | 52.16 Million USD | 64.612% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -16.063% |
| LivaNova PLC | 771.25 Million USD | 97.606% |
| 908 Devices Inc. | 25.32 Million USD | 27.095% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 94.049% |
| Nemaura Medical Inc. | -1.47 Million USD | 1350.413% |
| NeuroPace, Inc. | 48.12 Million USD | 61.637% |
| LENSAR, Inc. | 21.1 Million USD | 12.536% |
| Apyx Medical Corporation | 14.12 Million USD | -30.725% |
| Cutera, Inc. | 41.49 Million USD | 55.509% |
| BioSig Technologies, Inc. | 18 Thousand USD | -102461.106% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 82.092% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -35.603% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 97.922% |
| Axonics, Inc. | 274.55 Million USD | 93.276% |
| Outset Medical, Inc. | 29 Million USD | 36.341% |
| IRIDEX Corporation | 21.8 Million USD | 15.344% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 74.017% |
| IRadimed Corporation | 50.15 Million USD | 63.195% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -6332.404% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1599.692% |
| Telesis Bio, Inc. | 16.95 Million USD | -8.914% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 83.631% |
| Varex Imaging Corporation | 256.9 Million USD | 92.814% |
| Quipt Home Medical Corp. | 163.84 Million USD | 88.733% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 4647.044% |
| Pulmonx Corporation | 50.75 Million USD | 63.625% |
| Dynatronics Corporation | 7.63 Million USD | -141.795% |
| Modular Medical, Inc. | -768 Thousand USD | 2503.776% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -232.751% |
| Semler Scientific, Inc. | 61.2 Million USD | 69.835% |
| InMode Ltd. | 411.34 Million USD | 95.512% |
| Bruker Corporation | 1.51 Billion USD | 98.783% |
| Cytosorbents Corporation | 22.39 Million USD | 17.555% |
| DexCom, Inc. | 2.28 Billion USD | 99.193% |
| Align Technology, Inc. | 2.71 Billion USD | 99.321% |
| Viveve Medical, Inc. | 620 Thousand USD | -2877.58% |
| ZimVie Inc. | 290.38 Million USD | 93.643% |
| Movano Inc. | -158 Thousand USD | 11784.177% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 83.129% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -21603.502% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 94.979% |
| Profound Medical Corp. | 4.51 Million USD | -308.97% |
| Insulet Corporation | 1.15 Billion USD | 98.408% |
| enVVeno Medical Corporation | -546 Thousand USD | 3481.135% |
| Surmodics, Inc. | 93.05 Million USD | 80.161% |
| iCAD, Inc. | 14.53 Million USD | -27.002% |
| Nuwellis, Inc. | 4.98 Million USD | -270.48% |
| Biotricity, Inc. | 8.35 Million USD | -120.924% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 94.436% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 5241.523% |
| InspireMD, Inc. | 1.8 Million USD | -921.638% |
| PAVmed Inc. | -3.96 Million USD | 565.247% |
| BIOLASE, Inc. | 16.72 Million USD | -10.386% |
| Beyond Air, Inc. | -1.3 Million USD | 1512.471% |
| FONAR Corporation | 45.14 Million USD | 59.103% |
| AxoGen, Inc. | 127.87 Million USD | 85.563% |
| Vivani Medical, Inc. | -357 Thousand USD | 5271.148% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 90.539% |
| Inari Medical, Inc. | 434.56 Million USD | 95.752% |
| UFP Technologies, Inc. | 112.22 Million USD | 83.55% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -147363.847% |
| Tenon Medical, Inc. | 1.24 Million USD | -1387.591% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 22891.357% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -602.717% |
| AdaptHealth Corp. | 479.56 Million USD | 96.15% |
| Sintx Technologies, Inc. | 1.84 Million USD | -901.682% |
| NanoVibronix, Inc. | 1.53 Million USD | -1101.106% |
| Quanterix Corporation | 70.64 Million USD | 73.868% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 4647.044% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -31.302% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 65.023% |
| TransMedics Group, Inc. | 154.09 Million USD | 88.02% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -314.574% |
| NeuroMetrix, Inc. | 3.94 Million USD | -367.673% |
| Hyperfine, Inc. | 4.75 Million USD | -288.081% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 82.743% |
| Biomerica, Inc. | 611 Thousand USD | -2921.44% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 55.716% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 2463.9% |
| Silk Road Medical, Inc | 127.08 Million USD | 85.474% |